1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Review Commons, a pre-journal portable review platform

 

Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review

 

Washington DC, 9 December 2019 – Today ASAPbio and EMBO Press launch Review Commons, a platform for high-quality, journal-independent peer review of manuscripts from the life sciences before submission to a journal. Authors can submit preprints or unpublished manuscripts to Review Commons for expert peer review. The resulting Refereed Preprint, containing the manuscript, the reviewers’ reports plus any author responses empowers authors to make an informed decision on the best home for their paper, while the Review Commons platform expedites submission to 17 affiliate journals that have agreed to consider the transferred reviews without restarting the review process.

Read more...

EMBO welcomes first Global Investigators

 

Nine life scientists join the new EMBO Programme in its first year

 

Heidelberg, 3 December 2019 – EMBO has selected the first nine life scientists to join the Global Investigator Network, which was launched this year. These scientists, who are in the early stages of establishing independent laboratories, will receive support from EMBO to access career-enhancing training and networking opportunities.

Read more...

Exploring drug repurposing to treat glioblastoma

 

MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.

 

Heidelberg, 27 November 2019 – For a long time, cancer research has largely focused on so-called oncogenes – genes that can cause cancer when mutated. While targeting these genes has led to the successful development of a number of valuable drugs, this approach is hampered by the fact that tumours often become resistant to these treatments.

Read more...

Molecular Systems Biology appoints M. Madan Babu as new Chief Editor

 

Heidelberg, 25 November 2019 – EMBO Press is pleased to announce the appointment of systems biologist M. Madan Babu as the new Chief Editor of Molecular Systems Biology. Madan Babu, who heads the regulatory genomics and systems biology group at the MRC Laboratory of Molecular Biology in Cambridge, UK, takes up the post with immediate effect.

 

Read more...

Twenty-seven life scientists become EMBO Young Investigators

 

Heidelberg, 13 November 2019 – EMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators. They join a network of 129 current and 340 former Young Investigators, and will begin their four-year programme tenure in January 2020. During this time EMBO will provide financial and practical support as well as networking opportunities for the Young Investigators and their lab members.

 

Read more...

Strategies of a honey bee virus

 

Heidelberg, 23 October 2019 - The Israeli Acute Paralysis Virus is a pathogen that affects honey bees and has been linked to Colony Collapse Disorder, a key factor in decimating the bee population. Researchers have now analyzed in detail how the virus hijacks the cellular protein production machinery and misuses it for its own purposes. The research, published in The EMBO Journal, is an important step towards the development of strategies to fight the Colony Collapse Disorder.

Read more...

Exploring the effect of fasting on age-related diseases

 

Heidelberg, 21 October 2019 - There are many indications that fasting promotes longevity. In recent years, much attention has been devoted to so-called caloric restriction mimetics (CMRs), substances that simulate the health-promoting effects of fasting without the need of life-style change. In a study published in EMBO Molecular Medicine, a research team led by Oliver Kepp and Guido Kroemer at the French Medical Research Council (INSERM) reports the identification of a novel candidate CRM. The substance may prove useful in the further research for the treatment of age-related diseases.

Read more...

Updated fellowship programme for excellent postdocs

 

Salaried employment, contributions to social security schemes, leadership training and networking

 

Heidelberg, 15 October 2019 – Today EMBO announces an update of its programme fostering excellent postdoctoral researchers on their path to an independent research position. The updated EMBO Postdoctoral Fellowship scheme replaces fellows’ stipends with two-year salaried contracts from their host organizations that include social security payments as required by national and local laws and regulations.

Read more...

EMBO and ASAPbio to launch a pre-journal portable review platform

 

A multi-publisher partnership aims to streamline scientific publishing by producing refereed preprints

 

Heidelberg and San Francisco  September 30, 2019 — EMBO Press and ASAPbio have partnered to create Review Commons, a platform that peer-reviews research manuscripts in the life sciences before submission to a journal.  

Read more...

EMBO elects 56 new Members

 

Heidelberg, 11 June 2019 – EMBO announces today that 56 life scientists have been elected to its membership, joining a group of more than 1800 of the best researchers in Europe and around the world.

Read more...

M. Madan Babu and Paola Picotti honoured with EMBO Gold Medal

 

Heidelberg, 5 June 2019 – The EMBO Gold Medal 2019 has been awarded to two systems biologists, M. Madan Babu and Paola Picotti.

Read more...

EMBO launches Global Investigator Network

 

Connecting young research group leaders across the world

 

Heidelberg, 11 March 2019 – EMBO today launches the Global Investigator Programme. This new programme is intended for young life scientists who have started their laboratories in Chile, India, Singapore or Taiwan within the last six years. It provides the selected scientists with funding and platforms for networking with other life scientists in the same region and those in Europe, encouraging the establishment of cooperation across international borders.

Read more...

Towards a blood test for early-stage liver disease

 

Researchers uncover a set of proteins that are enriched in pre-symptomatic non-alcoholic fatty liver disease

 

Heidelberg, 1 March 2019 – One in four people in Western and Asian societies develop a build-up of fat in the liver as a result of an unhealthy diet. This disease – referred to as non-alcoholic fatty liver disease (NAFLD) – causes no symptoms initially but can develop into end-stage liver cirrhosis with limited treatment options. A discovery, published today in Molecular Systems Biology, paves the way for a simple blood test to detect early stages of NAFLD, opening up the possibility of preventing the development of liver cirrhosis through lifestyle changes or pharmaceutical intervention.

Read more...

FEBS | EMBO Women in Science Award 2019 awarded to Sara Linse

 

Heidelberg, 11 February 2019 – EMBO and the Federation of European Biochemical Societies (FEBS) announce Sara Linse of Lund University, Sweden, as the recipient of the 2019 FEBS | EMBO Women in Science Award.

Read more...